G60511.mp4 Review
It features a stainless steel scaffold covered with a thin layer of ePTFE (polytetrafluoroethylene), allowing it to act as a scaffold while providing a barrier against tissue ingrowth. Key Clinical and Regulatory Milestones
The iCARUS clinical trial demonstrated a 96.4% primary patency rate at 9 months, showing the device is highly effective for vascular treatment. g60511.mp4
Used for treating iliac arterial occlusive disease (narrowed arteries in the groin/leg area). It features a stainless steel scaffold covered with
the stent beyond recommended diameters, as this can lead to stent fracture. g60511.mp4
